US · ICCM
IceCure Medical Ltd
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Caesarea 3079504
- Website
- icecure-medical.com
Price · as of 2024-12-31
$0.30
Market cap 39.85M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $26.24 | +8,608.93% |
| Intrinsic Value(DCF) | $0.54 | +79.22% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | $0.00 | $15.67 | |||
| 2016 | $0.00 | $5.61 | |||
| 2017 | $0.00 | $0.00 | |||
| 2018 | $0.00 | $0.00 | |||
| 2019 | $0.00 | $0.00 | |||
| 2020 | $0.00 | $0.00 | |||
| 2021 | $2.38 | $27.27 | $10.70 | $0.00 | $0.00 |
| 2022 | $1.20 | $26.03 | $0.19 | $0.00 | $7.52 |
| 2023 | $1.24 | $26.88 | $0.00 | $0.00 | $0.00 |
| 2024 | $1.35 | $26.24 | $0.00 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates IceCure Medical Ltd's (ICCM) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $26.24
- Current price
- $0.30
- AI upside
- +8,608.93%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.54
+79.22% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| ICCM | IceCure Medical Ltd | $0.30 | 39.85M | +8,609% | +79% | — | — | -4.48 | 9.95 | 20.87 | -4.01 | — | 9.95 | 44.09% | -476.94% | -465.45% | -160.70% | -2098.40% | -105.69% | 0.07 | — | 1.95 | 1.41 | 0.46 | -625.00% | 192.00% | -282.00% | -18.39% | -2.28 | -1689.04% | 0.00% | 0.00% | 0.00% | -3.92 | -4.87 | 18.71 | -7.83 |
| BDMD | Baird Medical Investment … | $2.98 | 109.44M | +1,873% | +2% | +34% | +311% | 8.01 | 2.55 | 2.73 | 7.35 | 41.06 | 2.55 | 88.16% | 41.35% | 33.62% | 33.41% | 26.96% | 18.71% | 0.53 | 26.55 | 1.77 | 1.43 | 1.11 | 1951.00% | 1774.00% | 15056.00% | -9.08% | -0.18 | -18.05% | 0.00% | 0.00% | 0.00% | 7.76 | -12.97 | 3.21 | 3.60 |
| CTSO | Cytosorbents Corporation | $0.75 | 47.26M | +3,558% | -47% | — | — | -2.65 | 4.95 | 1.54 | -5.17 | — | 7.47 | 70.59% | -47.16% | -58.21% | -120.52% | -49.92% | -41.18% | 2.42 | -12.00 | 2.20 | 1.08 | -1.55 | -4154.00% | 1451.00% | -3488.00% | -26.76% | -1.47 | -47.32% | 0.00% | 0.00% | 0.00% | -4.68 | -5.34 | 2.21 | -8.19 |
| ECOR | electroCore, Inc. | $7.58 | 60.61M | +1,415% | +10,410% | — | — | -8.88 | 13.99 | 4.19 | -8.96 | — | 13.99 | 84.97% | -48.30% | -47.20% | -158.63% | 945.74% | -65.00% | 0.55 | — | 1.78 | 1.46 | -0.06 | -5351.00% | 5709.00% | -5329.00% | -6.59% | -0.76 | 544.51% | 0.00% | 0.00% | 0.00% | -8.03 | -14.06 | 3.88 | -7.53 |
| MDAI | Spectral AI, Inc. | $1.40 | 42.96M | +2,693% | -59% | — | — | -1.69 | -3.56 | 0.87 | -2.21 | — | -3.56 | 44.87% | -22.25% | -51.77% | 341.85% | 101.83% | -134.42% | -0.65 | -2.22 | 0.57 | 0.43 | 0.04 | -4257.00% | 6383.00% | -3052.00% | -35.62% | -0.52 | 142.31% | 0.00% | 0.00% | 0.00% | -3.85 | -2.76 | 0.86 | -4.86 |
| MDCX | Medicus Pharma Ltd. Commo… | $1.53 | 37.8M | — | — | — | — | -2.63 | 9.36 | — | -2.29 | — | 9.36 | 0.00% | — | — | -525.44% | 1700.21% | -295.90% | 0.10 | -35.21 | 2.33 | 1.81 | 0.34 | -2810.00% | — | 14643.00% | -34.93% | -4.44 | 1558.23% | 0.00% | 0.00% | 7.24% | -2.28 | -2.49 | — | -6.04 |
| PETS | PetMed Express, Inc. | $2.74 | 58.64M | +949% | -13% | -57% | -8% | -13.01 | 0.96 | 0.36 | 4.15 | — | 1.81 | 30.46% | -0.67% | -2.76% | -6.90% | -4.12% | -3.94% | 0.01 | — | 1.26 | 0.91 | -8.01 | -1892.00% | -1719.00% | 10361.00% | -0.48% | 0.08 | -1.06% | 0.22% | -2.90% | 0.22% | -18.19 | -70.47 | 0.12 | 3.02 |
| SRTS | Sensus Healthcare, Inc. | $4.11 | 67.51M | +2,671% | -38% | -86% | +183% | -9.71 | 1.56 | 2.73 | -5.40 | — | 1.56 | 43.18% | -37.50% | -28.09% | -14.85% | -27.07% | -13.40% | 0.01 | — | 9.72 | 5.96 | 2.16 | -21463.00% | -3426.00% | -10000.00% | 0.00% | 0.00 | 0.00% | 0.00% | 0.00% | 0.00% | -5.19 | — | 1.95 | 10.06 |
| TELA | TELA Bio, Inc. | $0.87 | 38.66M | +2,769% | +12% | — | — | -1.82 | 2.43 | 1.00 | -1.88 | — | 2.58 | 67.08% | -49.23% | -54.60% | -159.87% | -201.31% | -45.76% | 1.51 | -6.45 | 5.01 | 4.02 | 0.30 | -3480.00% | 1856.00% | 269.00% | -61.69% | -2.67 | -252.24% | 0.00% | 0.00% | 8.18% | -1.74 | -1.40 | 0.86 | -4.68 |
| TELO | Telomir Pharmaceuticals, … | $1.27 | 43.66M | — | — | — | — | -7.77 | 199.83 | — | 2652.56 | -28.50 | 199.83 | 0.00% | — | — | -810.18% | -813.89% | -542.25% | 0.15 | 2.82 | 1.94 | 1.86 | -24.43 | 2727.00% | — | 3137.00% | -3.95% | -7.45 | -337.09% | 0.00% | 0.00% | 0.99% | -10.40 | -25.11 | — | 50.93 |
About IceCure Medical Ltd
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
- CEO
- Eyal Shamir
- Employees
- 64
- Beta
- 2.21
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.54 ÷ $0.30) − 1 = +79.22% (DCF, example).